NCT07368062

Mental Health After Dexmedetomidine for Electrical Storm

Study Evaluating Dexmedetomidine in the Acute Treatment of Electrical Storm: Outpatient Follow-up of Mental Health INDices (SDATE OF MIND)

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 70 (estimated)
• Sponsor: Ottawa Heart Institute Research Corporation · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

The goal of the research study is to measure mental health and quality of life indices of individuals treated for electrical storm (ES). The consequences of being admitted to an intensive care unit (ICU) with electrical storm as well as the treatments patients would have received, are currently not well understood. Understanding the mental health burden of these treatments among survivors can provide insights into how to improve care. This is a study consisting of patients who participated in the SEDATE trial (dexmedetomidine vs usual standard of care to treat ES in the ICU). Patients who consent to participate in this study will be asked to complete a set of questionnaires 3-6 months after their ICU admission. The purpose of the questionnaires is to measure indices of mental health and health-related quality of life. Each questionnaire will take about 5-15 minutes to complete. If patients have a scheduled follow-up at the University of Ottawa Heart Institute, a member of the research team will meet with them during their clinic visit to complete the questionnaires. Otherwise, they can be completed over the telephone.

Conditions

• Mental Health

Interventions

Type	Name	Description
DRUG	Dexmedetomidine	Dexmedetomidine infusion during ICU admission for electrical storm
DRUG	Placebo	Placebo (standard of care, no dexmedetomidine), for treatment of electrical storm while admitted to ICU

Timeline

• Start date: 2025-03-15
• Primary completion: 2027-12-01
• Completion: 2028-06-01
• First posted: 2026-01-26
• Last updated: 2026-01-26

Locations

1 site across 1 country: Canada